Radiologists analyzed gadolinium retention research and identified limitations to our current understanding of gadolinium-based contrast agent (GBCA) retention risks in a recent JAMA viewpoint.

Researchers have developed an add-on for laser-scanning microscopes that can improve the quality of 2D and 3D imaging of the brain, according to a new study published in Optica.

Improving women’s understanding of baseline mammograms and their importance is necessary, according to new research published in the Journal of the American College of Radiology.

Medicaid expansion under the Affordable Care Act (ACA) failed to improve access to care for minorities and low-income patients with complex surgical needs, researchers reported in the Sept. 13 online edition of the Journal of the American College of Surgeons.

From taking swipes at specific drug companies on Twitter to promising to get pharmaceutical prices down “really, really substantially,” President Donald Trump has said a lot about lowering drug prices. However, many Americans aren’t buying into the rhetoric, according to a recent study.

Though major medical associations advise against prostate cancer screening in men over the age of 70, treatment in elderly populations costs Medicare more than $400 million a year, according to research published online Sept. 13 in JAMA Oncology. These costs include claims for CT, MRI and bone scans for diagnosis and follow-up imaging.

In 2018, cancer deaths will rise to 9.6 million worldwide, according to new data from the International Agency for Research on Cancer.

PET imaging is a common tool to establish the stage of a patient’s prostate cancer, but new research raises questions about its association with misdiagnosis and unnecessary changes in therapies. Benign tissues in the kidney, bowels and salivary glands may show increased prostate-specific membrane antigen (PSMA) expression, prompting experts to caution against relying solely on PSMA PET.